DCBLD2 and neoplasm: Figure 3a reports representative tissue slides of the TMA labeled with antibodies against AKAP12, DCBLD2, NTE5 and SPON1. Figure 3b reports the overall percentages of detection between tumor and normal samples. In Figure S3 further staining of DCBLD2 and NT5E at a higher resolution is illustrated.